Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Equity: 2017-2025

Historic Return on Equity for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -0.04%.

  • Organogenesis Holdings' Return on Equity fell 1.00% to -0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.04% for FY2024, which is 5.00% down from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Return on Equity is -0.04%, which was up 50.02% from -0.08% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Return on Equity registered a high of 0.44% during Q4 2021, and its lowest value of -0.11% during Q1 2025.
  • Over the past 3 years, Organogenesis Holdings' median Return on Equity value was -0.03% (recorded in 2024), while the average stood at -0.02%.
  • Per our database at Business Quant, Organogenesis Holdings' Return on Equity surged by 152bps in 2021 and then plummeted by 38bps in 2022.
  • Over the past 5 years, Organogenesis Holdings' Return on Equity (Quarterly) stood at 0.44% in 2021, then crashed by 38bps to 0.06% in 2022, then dropped by 4bps to 0.02% in 2023, then declined by 5bps to -0.04% in 2024, then decreased by 1bps to -0.04% in 2025.
  • Its Return on Equity stands at -0.04% for Q3 2025, versus -0.08% for Q2 2025 and -0.11% for Q1 2025.